APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurofeedback

Neurofeedback is a non-invasive method of direct brain function training. It is also a type of biofeedback and is therefore, also called EEG Biofeedback. It uses the electrodes (which act like tiny microphones) placed on the client's scalp to record and amplify the EEG, or brainwaves and control auditory, visual, and/or tactile feedback which allows learning to take place. This operant learning initiates self-regulation and enhances relaxation, both necessary components of good brain function.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Neurofeedback is a non-invasive method of direct brain function training. It is also a type of biofeedback and is therefore, also called EEG Biofeedback. It uses the electrodes (which act like tiny microphones) placed on the client's scalp to record and amplify the EEG, or brainwaves and control auditory, visual, and/or tactile feedback which allows learning to take place. This operant learning initiates self-regulation and enhances relaxation, both necessary components of good brain function.

Selected research

Market Outlook & Growth Opportunities

Global Neurofeedback Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchNeurofeedback Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurofeedback Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Neurofeedback Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurofeedback Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurofeedback Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Neurofeedback is a non-invasive method of direct brain function training. It is also a type of biofeedback and is therefore, also called EEG Biofeedback. It uses the electrodes (which act like tiny microphones) placed on the client's scalp to record and amplify the EEG, or brainwaves and control auditory, visual, and/or tactile feedback which allows learning to take place. This operant learning initiates self-regulation and enhances relaxation, both necessary components of good brain function.

Global Neurofeedback key players include Mitsar, InteraXon, Mind Media, NeuroCare, Thought Technology, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share over 55%, followed by Europe and China, both have a share over 30%.

Read the full market overview

In terms of product, Low-energy System is the largest segment, with a share over 25%. And in terms of application, the largest application is Non-medical, followed by ADHD Treatment, Other Clinic Use, etc.

This report provides an overview of the global Neurofeedback market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurofeedback and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurofeedback sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurofeedback market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurofeedback Segment by Company

BrainMaster Technologies

BEE Medic

Brainquiry

Mitsar

Thought Technology

Mind Media

Wearable Sensing

InteraXon

NeuroCare

Macrotellect

Titan Commerce

NeuroField

Neurofeedback Segment by Type

Slow Cortical Potential Neurofeedback (SCP-NF)

Low-Energy Neurofeedback System (LENS)

Hemoencephalographic (HEG) Neurofeedback

Others

Neurofeedback Segment by Application

ADHD Treatment

Other Clinic Use

Non-Medical

Neurofeedback Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neurofeedback status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neurofeedback market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurofeedback significant trends, drivers, influence factors in global and regions.

6. To analyze Neurofeedback competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurofeedback market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurofeedback and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurofeedback.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurofeedback market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurofeedback industry.

Chapter 3: Detailed analysis of Neurofeedback manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neurofeedback in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neurofeedback in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neurofeedback Industry Trends Table 2. Neurofeedback Industry Drivers Table 3. Neurofeedback Industry Opportunities and Challenges Table 4. Neurofeedback Industry Restraints Table 5. Global Neurofeedback Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neurofeedback Revenue Share by Company (2021-2026) Table 7. Global Neurofeedback Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Neurofeedback Sales Volume Share by Company (2021-2026) Table 9. Global Neurofeedback Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Neurofeedback Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neurofeedback Key Company Manufacturing Base & Headquarters Table 12. Global Neurofeedback Company, Product Type & Application Table 13. Global Neurofeedback Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurofeedback by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Slow Cortical Potential Neurofeedback (SCP-NF) Table 18. Significant Companies of Low-Energy Neurofeedback System (LENS) Table 19. Significant Companies of Hemoencephalographic (HEG) Neurofeedback Table 20. Significant Companies of Others Table 21. Global Neurofeedback Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Neurofeedback Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Neurofeedback Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Neurofeedback Sales Volume Share by Type (2021-2026) Table 25. Global Neurofeedback Sales Volume Share by Type (2027-2032) Table 26. Global Neurofeedback Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Neurofeedback Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Neurofeedback Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Neurofeedback Sales Value Share by Type (2021-2026) Table 30. Global Neurofeedback Sales Value Share by Type (2027-2032) Table 31. Significant Companies of ADHD Treatment Table 32. Significant Companies of Other Clinic Use Table 33. Significant Companies of Non-Medical Table 34. Global Neurofeedback Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Neurofeedback Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Neurofeedback Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Neurofeedback Sales Volume Share by Application (2021-2026) Table 38. Global Neurofeedback Sales Volume Share by Application (2027-2032) Table 39. Global Neurofeedback Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Neurofeedback Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Neurofeedback Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Neurofeedback Sales Value Share by Application (2021-2026) Table 43. Global Neurofeedback Sales Value Share by Application (2027-2032) Table 44. Global Neurofeedback Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Neurofeedback Sales by Region (2021-2026) & (K Units) Table 46. Global Neurofeedback Sales Market Share by Region (2021-2026) Table 47. Global Neurofeedback Sales by Region (2027-2032) & (K Units) Table 48. Global Neurofeedback Sales Market Share by Region (2027-2032) Table 49. Global Neurofeedback Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Neurofeedback Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Neurofeedback Sales Value Share by Region (2021-2026) Table 52. Global Neurofeedback Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Neurofeedback Sales Value Share by Region (2027-2032) Table 54. Global Neurofeedback Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Neurofeedback Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Neurofeedback Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Neurofeedback Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Neurofeedback Sales by Country (2021-2026) & (K Units) Table 59. Global Neurofeedback Sales Market Share by Country (2021-2026) Table 60. Global Neurofeedback Sales by Country (2027-2032) & (K Units) Table 61. Global Neurofeedback Sales Market Share by Country (2027-2032) Table 62. Global Neurofeedback Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Neurofeedback Sales Value Market Share by Country (2021-2026) Table 64. Global Neurofeedback Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Neurofeedback Sales Value Market Share by Country (2027-2032) Table 66. BrainMaster Technologies Company Information Table 67. BrainMaster Technologies Business Overview Table 68. BrainMaster Technologies Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. BrainMaster Technologies Neurofeedback Product Portfolio Table 70. BrainMaster Technologies Recent Development Table 71. BEE Medic Company Information Table 72. BEE Medic Business Overview Table 73. BEE Medic Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. BEE Medic Neurofeedback Product Portfolio Table 75. BEE Medic Recent Development Table 76. Brainquiry Company Information Table 77. Brainquiry Business Overview Table 78. Brainquiry Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Brainquiry Neurofeedback Product Portfolio Table 80. Brainquiry Recent Development Table 81. Mitsar Company Information Table 82. Mitsar Business Overview Table 83. Mitsar Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Mitsar Neurofeedback Product Portfolio Table 85. Mitsar Recent Development Table 86. Thought Technology Company Information Table 87. Thought Technology Business Overview Table 88. Thought Technology Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Thought Technology Neurofeedback Product Portfolio Table 90. Thought Technology Recent Development Table 91. Mind Media Company Information Table 92. Mind Media Business Overview Table 93. Mind Media Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Mind Media Neurofeedback Product Portfolio Table 95. Mind Media Recent Development Table 96. Wearable Sensing Company Information Table 97. Wearable Sensing Business Overview Table 98. Wearable Sensing Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Wearable Sensing Neurofeedback Product Portfolio Table 100. Wearable Sensing Recent Development Table 101. InteraXon Company Information Table 102. InteraXon Business Overview Table 103. InteraXon Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. InteraXon Neurofeedback Product Portfolio Table 105. InteraXon Recent Development Table 106. NeuroCare Company Information Table 107. NeuroCare Business Overview Table 108. NeuroCare Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. NeuroCare Neurofeedback Product Portfolio Table 110. NeuroCare Recent Development Table 111. Macrotellect Company Information Table 112. Macrotellect Business Overview Table 113. Macrotellect Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Macrotellect Neurofeedback Product Portfolio Table 115. Macrotellect Recent Development Table 116. Titan Commerce Company Information Table 117. Titan Commerce Business Overview Table 118. Titan Commerce Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Titan Commerce Neurofeedback Product Portfolio Table 120. Titan Commerce Recent Development Table 121. NeuroField Company Information Table 122. NeuroField Business Overview Table 123. NeuroField Neurofeedback Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. NeuroField Neurofeedback Product Portfolio Table 125. NeuroField Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Neurofeedback Distributors List Table 129. Neurofeedback Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Neurofeedback Product Image Figure 2. Global Neurofeedback Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurofeedback Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neurofeedback Sales (2021-2032) & (K Units) Figure 5. Global Neurofeedback Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Neurofeedback Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Slow Cortical Potential Neurofeedback (SCP-NF) Image Figure 10. Low-Energy Neurofeedback System (LENS) Image Figure 11. Hemoencephalographic (HEG) Neurofeedback Image Figure 12. Others Image Figure 13. Global Neurofeedback Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Neurofeedback Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Neurofeedback Sales Volume Share by Type (2021-2032) Figure 16. Global Neurofeedback Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Neurofeedback Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Neurofeedback Sales Value Share by Type (2021-2032) Figure 19. ADHD Treatment Image Figure 20. Other Clinic Use Image Figure 21. Non-Medical Image Figure 22. Global Neurofeedback Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Neurofeedback Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Neurofeedback Sales Volume Share by Application (2021-2032) Figure 25. Global Neurofeedback Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Neurofeedback Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Neurofeedback Sales Value Share by Application (2021-2032) Figure 28. Global Neurofeedback Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Neurofeedback Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Neurofeedback Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Neurofeedback Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Neurofeedback Sales Value (2021-2032) & (US$ Million) Figure 33. North America Neurofeedback Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Neurofeedback Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Neurofeedback Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Neurofeedback Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Neurofeedback Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Neurofeedback Sales Value (2021-2032) & (US$ Million) Figure 39. South America Neurofeedback Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Neurofeedback Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Neurofeedback Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Neurofeedback Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Neurofeedback Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Neurofeedback Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Neurofeedback Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Neurofeedback Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Slow Cortical Potential Neurofeedback (SCP-NF)
  • Low-Energy Neurofeedback System (LENS)
  • Hemoencephalographic (HEG) Neurofeedback
  • Others
Applications
  • ADHD Treatment
  • Other Clinic Use
  • Non-Medical
Companies covered
  • BrainMaster Technologies
  • BEE Medic
  • Brainquiry
  • Mitsar
  • Thought Technology
  • Mind Media
  • Wearable Sensing
  • InteraXon
  • NeuroCare
  • Macrotellect
  • Titan Commerce
  • NeuroField

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurofeedback Sales Value (2021-2032)
  4. 1.2.2 Global Neurofeedback Sales Volume (2021-2032)
  5. 1.2.3 Global Neurofeedback Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neurofeedback Market Dynamics
  1. 2.1 Neurofeedback Industry Trends
  2. 2.2 Neurofeedback Industry Drivers
  3. 2.3 Neurofeedback Industry Opportunities and Challenges
  4. 2.4 Neurofeedback Industry Restraints
3 Neurofeedback Market by Company
  1. 3.1 Global Neurofeedback Company Revenue Ranking in 2025
  2. 3.2 Global Neurofeedback Revenue by Company (2021-2026)
  3. 3.3 Global Neurofeedback Sales Volume by Company (2021-2026)
  4. 3.4 Global Neurofeedback Average Price by Company (2021-2026)
  5. 3.5 Global Neurofeedback Company Ranking (2024-2026)
  6. 3.6 Global Neurofeedback Company Manufacturing Base and Headquarters
  7. 3.7 Global Neurofeedback Company Product Type and Application
  8. 3.8 Global Neurofeedback Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neurofeedback Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neurofeedback Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neurofeedback Market by Type
  1. 4.1 Neurofeedback Type Introduction
  2. 4.1.1 Slow Cortical Potential Neurofeedback (SCP-NF)
  3. 4.1.2 Low-Energy Neurofeedback System (LENS)
  4. 4.1.3 Hemoencephalographic (HEG) Neurofeedback
  5. 4.1.4 Others
  6. 4.2 Global Neurofeedback Sales Volume by Type
  7. 4.2.1 Global Neurofeedback Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neurofeedback Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Neurofeedback Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Neurofeedback Sales Value by Type
  11. 4.3.1 Global Neurofeedback Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Neurofeedback Sales Value by Type (2021-2032)
  13. 4.3.3 Global Neurofeedback Sales Value Share by Type (2021-2032)
5 Neurofeedback Market by Application
  1. 5.1 Neurofeedback Application Introduction
  2. 5.1.1 ADHD Treatment
  3. 5.1.2 Other Clinic Use
  4. 5.1.3 Non-Medical
  5. 5.2 Global Neurofeedback Sales Volume by Application
  6. 5.2.1 Global Neurofeedback Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurofeedback Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Neurofeedback Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Neurofeedback Sales Value by Application
  10. 5.3.1 Global Neurofeedback Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurofeedback Sales Value by Application (2021-2032)
  12. 5.3.3 Global Neurofeedback Sales Value Share by Application (2021-2032)
6 Neurofeedback Regional Sales and Value Analysis
  1. 6.1 Global Neurofeedback Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurofeedback Sales by Region (2021-2032)
  3. 6.2.1 Global Neurofeedback Sales by Region: 2021-2026
  4. 6.2.2 Global Neurofeedback Sales by Region (2027-2032)
  5. 6.3 Global Neurofeedback Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neurofeedback Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neurofeedback Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neurofeedback Sales Value by Region (2027-2032)
  9. 6.5 Global Neurofeedback Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neurofeedback Sales Value (2021-2032)
  12. 6.6.2 North America Neurofeedback Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neurofeedback Sales Value (2021-2032)
  15. 6.7.2 Europe Neurofeedback Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neurofeedback Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neurofeedback Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neurofeedback Sales Value (2021-2032)
  21. 6.9.2 South America Neurofeedback Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neurofeedback Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neurofeedback Sales Value Share by Country, 2025 VS 2032
7 Neurofeedback Country-level Sales and Value Analysis
  1. 7.1 Global Neurofeedback Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neurofeedback Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neurofeedback Sales by Country (2021-2032)
  4. 7.3.1 Global Neurofeedback Sales by Country (2021-2026)
  5. 7.3.2 Global Neurofeedback Sales by Country (2027-2032)
  6. 7.4 Global Neurofeedback Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neurofeedback Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neurofeedback Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neurofeedback Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neurofeedback Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neurofeedback Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neurofeedback Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neurofeedback Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neurofeedback Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neurofeedback Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neurofeedback Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neurofeedback Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neurofeedback Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neurofeedback Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neurofeedback Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neurofeedback Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neurofeedback Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neurofeedback Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neurofeedback Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neurofeedback Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neurofeedback Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neurofeedback Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neurofeedback Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neurofeedback Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neurofeedback Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neurofeedback Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neurofeedback Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neurofeedback Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neurofeedback Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neurofeedback Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neurofeedback Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neurofeedback Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neurofeedback Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neurofeedback Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neurofeedback Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neurofeedback Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neurofeedback Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neurofeedback Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neurofeedback Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neurofeedback Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neurofeedback Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neurofeedback Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neurofeedback Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neurofeedback Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neurofeedback Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neurofeedback Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neurofeedback Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neurofeedback Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neurofeedback Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neurofeedback Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neurofeedback Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neurofeedback Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neurofeedback Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neurofeedback Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neurofeedback Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neurofeedback Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neurofeedback Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neurofeedback Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neurofeedback Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neurofeedback Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neurofeedback Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neurofeedback Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neurofeedback Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neurofeedback Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neurofeedback Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neurofeedback Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neurofeedback Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neurofeedback Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neurofeedback Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neurofeedback Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neurofeedback Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neurofeedback Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neurofeedback Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neurofeedback Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neurofeedback Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neurofeedback Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neurofeedback Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neurofeedback Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neurofeedback Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neurofeedback Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neurofeedback Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neurofeedback Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neurofeedback Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neurofeedback Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neurofeedback Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neurofeedback Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neurofeedback Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BrainMaster Technologies
  2. 8.1.1 BrainMaster Technologies Company Information
  3. 8.1.2 BrainMaster Technologies Business Overview
  4. 8.1.3 BrainMaster Technologies Neurofeedback Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BrainMaster Technologies Neurofeedback Product Portfolio
  6. 8.1.5 BrainMaster Technologies Recent Developments
  7. 8.2 BEE Medic
  8. 8.2.1 BEE Medic Company Information
  9. 8.2.2 BEE Medic Business Overview
  10. 8.2.3 BEE Medic Neurofeedback Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BEE Medic Neurofeedback Product Portfolio
  12. 8.2.5 BEE Medic Recent Developments
  13. 8.3 Brainquiry
  14. 8.3.1 Brainquiry Company Information
  15. 8.3.2 Brainquiry Business Overview
  16. 8.3.3 Brainquiry Neurofeedback Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Brainquiry Neurofeedback Product Portfolio
  18. 8.3.5 Brainquiry Recent Developments
  19. 8.4 Mitsar
  20. 8.4.1 Mitsar Company Information
  21. 8.4.2 Mitsar Business Overview
  22. 8.4.3 Mitsar Neurofeedback Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mitsar Neurofeedback Product Portfolio
  24. 8.4.5 Mitsar Recent Developments
  25. 8.5 Thought Technology
  26. 8.5.1 Thought Technology Company Information
  27. 8.5.2 Thought Technology Business Overview
  28. 8.5.3 Thought Technology Neurofeedback Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Thought Technology Neurofeedback Product Portfolio
  30. 8.5.5 Thought Technology Recent Developments
  31. 8.6 Mind Media
  32. 8.6.1 Mind Media Company Information
  33. 8.6.2 Mind Media Business Overview
  34. 8.6.3 Mind Media Neurofeedback Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mind Media Neurofeedback Product Portfolio
  36. 8.6.5 Mind Media Recent Developments
  37. 8.7 Wearable Sensing
  38. 8.7.1 Wearable Sensing Company Information
  39. 8.7.2 Wearable Sensing Business Overview
  40. 8.7.3 Wearable Sensing Neurofeedback Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Wearable Sensing Neurofeedback Product Portfolio
  42. 8.7.5 Wearable Sensing Recent Developments
  43. 8.8 InteraXon
  44. 8.8.1 InteraXon Company Information
  45. 8.8.2 InteraXon Business Overview
  46. 8.8.3 InteraXon Neurofeedback Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 InteraXon Neurofeedback Product Portfolio
  48. 8.8.5 InteraXon Recent Developments
  49. 8.9 NeuroCare
  50. 8.9.1 NeuroCare Company Information
  51. 8.9.2 NeuroCare Business Overview
  52. 8.9.3 NeuroCare Neurofeedback Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 NeuroCare Neurofeedback Product Portfolio
  54. 8.9.5 NeuroCare Recent Developments
  55. 8.10 Macrotellect
  56. 8.10.1 Macrotellect Company Information
  57. 8.10.2 Macrotellect Business Overview
  58. 8.10.3 Macrotellect Neurofeedback Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Macrotellect Neurofeedback Product Portfolio
  60. 8.10.5 Macrotellect Recent Developments
  61. 8.11 Titan Commerce
  62. 8.11.1 Titan Commerce Company Information
  63. 8.11.2 Titan Commerce Business Overview
  64. 8.11.3 Titan Commerce Neurofeedback Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Titan Commerce Neurofeedback Product Portfolio
  66. 8.11.5 Titan Commerce Recent Developments
  67. 8.12 NeuroField
  68. 8.12.1 NeuroField Company Information
  69. 8.12.2 NeuroField Business Overview
  70. 8.12.3 NeuroField Neurofeedback Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 NeuroField Neurofeedback Product Portfolio
  72. 8.12.5 NeuroField Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurofeedback Value Chain Analysis
  2. 9.1.1 Neurofeedback Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurofeedback Sales Mode & Process
  6. 9.2 Neurofeedback Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurofeedback Distributors
  9. 9.2.3 Neurofeedback Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst